All

Results: 34621-34632 of 47677

Sangamo Therapeutics Announces Data From Novel Proprietary Neurotropic AAV Capsid Demonstrating Industry-leading Blood-brain Barrier Penetration and Brain Transduction in NHPs

PR Newswire associated0

As phase I of 511MW project is connected to grid, TrinaTracker's Vanguard 1P makes Uzbekistan greener

PR Newswire associated0

New Webinar: Clarivate in the Age of AI - Empowering Our Life Sciences & Healthcare Customers to Create a Healthier Tomorrow

PR Newswire associated0

JINHAN FAIR - Trade Show You Can't Miss in 2024 to Meet the Home & Gift Trends Ahead

PR Newswire associated0

Waters Advances Battery Electrode Design and Performance Analysis with New Rheo-IS Accessory

Takeda Announces Positive Topline Results from Phase 2 Study Evaluating Mezagitamab (TAK-079), a Potential Best-in-Class Anti-CD38 Monoclonal Antibody, for Primary Immune Thrombocytopenia

First Doses of BRUKINSA® provided to Patients with Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries Under Collaboration of The Max Foundation, BeiGene, and the BeiGene Foundation

Transform Pharmaceutical Authoring Processes With Fonto Integrated Authoring Platform

PR Newswire associated0

Media Alert: IBM Applauds EU Parliament's Approval of the EU AI Act

Inside information: Henrica Ginström appointed as Citycon's new CEO

Sports company PUMA reduced its greenhouse gas emissions by 24% in 2023 compared to 2022, despite a strong sales growth. (Photo: Business Wire)

PUMA Reduces Greenhouse Gas Emissions by 24% in 2023

Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights